Literature DB >> 27540826

Pediatric intracranial dural arteriovenous fistulas: age-related differences in clinical features, angioarchitecture, and treatment outcomes.

Steven W Hetts1, Parham Moftakhar1, Neil Maluste2, Heather J Fullerton3, Daniel L Cooke1, Matthew R Amans1, Christopher F Dowd1,3,4,5, Randall T Higashida1,3,4,5, Van V Halbach1,3,4,5.   

Abstract

OBJECTIVE Intracranial dural arteriovenous fistulas (DAVFs) are rare in children. This study sought to better characterize DAVF presentation, angioarchitecture, and treatment outcomes. METHODS Children with intracranial DAVFs between 1986 and 2013 were retrospectively identified from the neurointerventional database at the authors' institution. Demographics, clinical presentation, lesion angioarchitecture, treatment approaches, angiographic outcomes, and clinical outcomes were assessed. RESULTS DAVFs constituted 5.7% (22/423) of pediatric intracranial arteriovenous shunting lesions. Twelve boys and 10 girls presented between 1 day and 18 years of age; boys presented at a median of 1.3 years and girls presented at a median of 4.9 years. Four of 8 patients ≤ 1 year of age presented with congestive heart failure compared with 0/14 patients > 1 year of age (p = 0.01). Five of 8 patients ≤ 1 year old presented with respiratory distress compared with 0/14 patients > 1 year old (p = 0.0021). Ten of 14 patients > 1 year old presented with focal neurological deficits compared with 0/8 patients ≤ 1 year old (p = 0.0017). At initial angiography, 16 patients harbored a single intracranial DAVF and 6 patients had 2-6 DAVFs. Eight patients (38%) experienced DAVF obliteration by the end of treatment. Good clinical outcome (modified Rankin Scale score 0-2) was documented in 77% of patients > 1 year old at presentation compared with 57% of patients ≤ 1 year old at presentation. Six patients (27%) died. CONCLUSIONS Young children with DAVFs presented predominantly with cardiopulmonary symptoms, while older children presented with focal neurological deficits. Compared with other pediatric vascular shunts, DAVFs had lower rates of angiographic obliteration and poorer clinical outcomes.

Entities:  

Keywords:  AVM = arteriovenous malformation; CCA = common carotid artery; CHF = congestive heart failure; CI = confidence interval; DAVF; DAVF = dural arteriovenous fistula; DSA = digital subtraction angiogram; DSM = dural sinus malformation; NGAVF = non-Galenic pial arteriovenous fistula; OR = odds ratio; SSS = superior sagittal sinus; VOGM = vein of Galen malformation; cardiopulmonary; dural arteriovenous fistula; mRS = modified Rankin Scale; neurological deficit; vascular disorders

Mesh:

Year:  2016        PMID: 27540826     DOI: 10.3171/2016.5.PEDS15740

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  5 in total

1.  Frequency and characteristics associated with inherited thrombophilia in patients with intracranial dural arteriovenous fistula.

Authors:  Sara C LaHue; Helen Kim; Ludmila Pawlikowska; Jeffrey Nelson; Daniel L Cooke; Steven W Hetts; Vineeta Singh
Journal:  J Neurosurg       Date:  2018-04-01       Impact factor: 5.115

Review 2.  Childhood stroke.

Authors:  Peter B Sporns; Heather J Fullerton; Sarah Lee; Helen Kim; Warren D Lo; Mark T Mackay; Moritz Wildgruber
Journal:  Nat Rev Dis Primers       Date:  2022-02-24       Impact factor: 52.329

3.  Rare occurrence of dural arteriovenous fistula in a child: Multi-modality imaging and literature review.

Authors:  Varun Yadav; Shuchi Bhatt; Saumya Dangwal
Journal:  Radiol Case Rep       Date:  2021-01-30

4.  Paediatric intracranial dural arteriovenous shunts: types, clinical presentation and therapeutic management.

Authors:  Stanislas J Smajda; Michael Söderman; Georg Dorfmüller; Nathalie Dorison; Marie-Claire Nghe; Georges L Rodesch
Journal:  Brain Commun       Date:  2022-02-23

5.  Progress in research on intracranial multiple dural arteriovenous fistulas.

Authors:  Yunbao Guo; Jing Yu; Ying Zhao; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.